Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE DATED JULY 1, 2010 - VIVOS INC | exhibit_99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
Current Report
Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 1, 2010
ADVANCED MEDICAL ISOTOPE CORPORATION
(Name of registrant as specified in its charter)
|
Delaware
|
0-53497
|
80-0138937
|
|
(State or other jurisdiction of
Incorporation or organization)
|
(Commission File Number)
|
(I.R.S. Employer
Identification Number)
|
|
8131 W. Grandridge Blvd. Suite 101, Kennewick WA 99336
|
99336
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code: (509) 736-4000
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1
Section 8 - Other Events
Item 8.01 Other Events.
On July 1, 2010, Advanced Medical Isotope Corporation announced that the company is experiencing a strengthening of the underlying economic drivers that continue to make AMIC a compelling investment opportunity.
Section 9 - Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.
| Exhibit No. | Description |
| 99.1 | Press Release dated July 1, 2010 |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ADVANCED MEDICAL ISOTOPE CORPORATION | |||
|
Date: July 2, 2010
|
By:
|
/s/ James C. Katzaroff | |
| Name: | James C. Katzaroff | ||
| Title: | Chairman and Chief Executive Officer | ||
2